Not to be confused with next generation sequencers (NGS), gene mapping systems are another tool for analyzing DNA molecules. Gene mapping systems are not as detailed as NGS systems, but instead provide information about where certain sequences appear on a chromosome. They provide information complementary to NGS results. The information that gene mapping systems provide […]
Company Announcements Consumer DNA firm Gene by Gene acquired sequencing data management firm Arpeggi in August. Illumina partnered with Global Genomics Group to investigate novel biomarkers and biological pathways involved in the development and diagnosis of cardiovascular diseases. Illumina will conduct whole-genome sequencing as part of a pan-omic study. In September, Illumina applied the EU’s […]
Company Announcements In September, X-Rite entered into a long-term partnership with MAC Group China for its photo portfolio. Centice named John Goehrke CEO in October. Most recently, he was CEO at Nextreme Thermo Solutions. Product Introductions BYK-Gardner introduced in September the portable BYK-mac i spectrophotometer for the quantification of fluorescence light. SciAps released the portable […]
Company Announcements Accelrys elected Heidi Melin, chief marketing officer at Plex Systems, to its Board in July. ChemAxon agreed to distribute Patcore’s CRAIS products globally excluding Japan. Certara partnered in September with the Critical Path Institute to develop a physiologically based pharmacokinetic model of the human lung built in conjunction with its Simcyp Population–based Simulator. […]
Uncertainty surrounding the legal requirements for conducting drug trials in India has slowed trial activity. In 2011, India was responsible for $450 million worth of clinical trials. Earlier this year, India’s Supreme Court stopped 157 clinical trials, requiring they undergo review. Also, the government introduced rules making companies responsible for the injury or death of […]
Adoption of biosimilar drugs by EU countries has been slower than expected, despite the cost savings they could produce. Currently, spending in developed countries on biosimilars totals less than 0.5% of all spending on biologic drugs. Physician caution, the relatively minor 20%–30% price savings per drugs and a small number of biosimilar manufacturers have deterred […]
R&D expenditures by UK businesses declined 2% in 2012 in current prices to £17.1 billion ($27.1 billion). In constant prices, they declined 4%. Total civil R&D expenditures, which excludes defense R&D spending, declined 1% to make up 91% of total UK business R&D spending. Pharmaceutical R&D showed the largest decline, falling 15% in current prices, […]
The US government has announced a budget agreement that eliminates sequestration for fiscal 2014. As a result, non-defense discretionary spending is estimated to increase 4.7% to $491 billion. However, final appropriations for individual agencies have yet to be determined. Optimism is high regarding budgets for research agencies because the standard budget process, in which Congressional […]
Global gross expenditures on R&D (GERD) are estimated to increase 2.7% in 2013 to $1,558 billion in terms of purchasing power parity, or 1.8% of GDP. In 2014, GERD is expected to grow 3.9%. The top 10 countries accounted for about 80% of GERD. Asia, the Americas, Europe and Rest of World accounted for 38%, […]
An analysis of the 12 largest research-based biopharmaceutical firms found that, between 2010 and 2013, these companies did not refill their drug pipelines at a sufficient rate to compensate for the new drugs released, the failure of compounds in development, and lower sales forecasts for compounds in late-stage development. Consequently, the value of their drug […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
